|
|
|
Corporate Profile: Edimer Pharmaceuticals
| Summary: |
Edimer Pharmaceuticals is focused on the development of EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED).
|
| Address (HQ): |
55 Cambridge Parkway
Suite 102W
Cambridge, MA 02142 |
| Phone
#'s (HQ): |
| Main |
(617) 758-4300 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
(866) 334-4240 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
